Laura Amaducci
About
In The Last Decade
Laura Amaducci
23 papers receiving 340 citations
Peers
Comparison fields: 5 of 78
- Oncology 160
- Molecular Biology 132
- Cancer Research 88
- Pulmonary and Respiratory Medicine 60
- Physiology 37
Countries citing papers authored by Laura Amaducci
This map shows the geographic impact of Laura Amaducci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Amaducci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Amaducci more than expected).
Fields of papers citing papers by Laura Amaducci
This network shows the impact of papers produced by Laura Amaducci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Amaducci. The network helps show where Laura Amaducci may publish in the future.
Co-authorship network of co-authors of Laura Amaducci
This figure shows the co-authorship network connecting the top 25 collaborators of Laura Amaducci. A scholar is included among the top collaborators of Laura Amaducci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Amaducci. Laura Amaducci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 2 | |
| 5 | 7 | |
| 6 | 10 | |
| 7 | 73 | |
| 8 | 20 | |
| 9 | 19 | |
| 10 | 18 | |
| 11 | 5 | |
| 12 | 55 | |
| 13 | 19 | |
| 14 | 13 | |
| 15 | 24 | |
| 16 | 3 | |
| 17 | 9 | |
| 18 | [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)]. | 1 |
| 19 | "Normal" pressure hydrocephalus in chronic inflammatory diseases: a clinical and laboratory study. | 1 |
| 20 | [Lecithin: cholesterol acyl-transferase activity in the plasma of patients with multiple sclerosis]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.